Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Acinetobacter baumanniihy pothetical protein A1S-1462 protein and preparation method and application thereof

An Acinetobacter baumannii and protein technology, applied in the biological field, can solve the problems of complex components, large toxic and side effects, and achieve the effects of high expression and controllable quality and safety.

Active Publication Date: 2015-08-26
ARMY MEDICAL UNIV
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above-mentioned whole-bacteria vaccines and outer-membrane complex vaccines have complex components and contain a large amount of endotoxins, which have relatively large toxic and side effects on the body. Therefore, it is an inevitable trend to develop a quality-controllable, safe and effective Acinetobacter baumannii vaccine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Acinetobacter baumanniihy pothetical protein A1S-1462 protein and preparation method and application thereof
  • Acinetobacter baumanniihy pothetical protein A1S-1462 protein and preparation method and application thereof
  • Acinetobacter baumanniihy pothetical protein A1S-1462 protein and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0079] Example 1: Cloning of hypothetical proteins from Acinetobacter baumannii

[0080] 1. Firstly, according to the gene sequence of Acinetobacter baumannii 17978 standard strain A1S_1462, use bioinformatics software to conduct structural analysis. For the analysis results, see the attached Image 6 , so as to determine the gene fragment of the hypothetical protein that needs to be amplified.

[0081] 2. According to the analysis results, the PCR method was used to amplify the gene fragment of the hypothetical protein using the whole genome of Acinetobacter baumannii 17978 as a template. The amplification steps were as follows:

[0082] 1) Design the PCR primers as follows, which are SEQ ID NO: 7-8 (the base sequence of the restriction site is underlined)

[0083] Forward primer PA1S1462B1: SEQ ID NO.7

[0084] 5'-CGC GGATCC ATGGCACCTGTAAAAGAACAAAAAAT-3'

[0085] BamH Ⅰ

[0086] Reverse primer PA1S1462N2: SEQ ID NO.8

[0087] 5'-TTAT GCGGCCGC CTTACTTTTTTTGTAGCTGCG-3'...

Embodiment 2

[0117] Example 2: Induced expression, purification and identification of expression form of hypothetical protein of Acinetobacter baumannii-17978 in prokaryotic expression system-Escherichia coli

[0118] 1. Induced expression of target protein

[0119] 1) Take 100 μL of the pGEX-6P-2-A1S_1462 / XL-1blue bacterial solution that was correctly identified by double enzyme digestion and add it to 10 mL of Amp-resistant TB medium, cultivate overnight at 100 rpm at 37°C, take 2 ml of the overnight cultured bacterial solution and add it to 18 mL In the Amp-resistant TB medium (the rest of the bacterial solution is stored in a refrigerator at 4°C for later use), culture at 37°C for 2-3 hours at a rotation speed of 250rpm, and when the secondary activation reaches OD600 of 0.8-1.2, add 4.4 μL of IPTG to make it The final concentration was 200 μM, and then placed on a shaker to induce expression at 30°C for 3 hours, and then induced expression at 16°C overnight.

[0120] 2) Take out the ...

Embodiment 3

[0125] Example 3: Preparation of hypothetical protein antigens

[0126] 1. Amplify culture to obtain protein

[0127] Take 400 μL of the spare pGEX-6P-2-A1S_1462 / XL-1blue bacterial solution stored in a refrigerator at 4°C and add it to 100 mL of LB medium containing Amp resistance for one activation, culture at 200 rpm at 37°C overnight, and add to 2L containing Amp Perform secondary activation in resistant LB medium, culture at 37°C for 3-4h until OD600 is 1.2, add 420ml of IPTG (final concentration: 200uM) and induce in a shaker at 30°C for 3h, then centrifuge at 6000rpm for 5min to collect the bacteria , after adding 80ml of PBS to resuspend the bacterial cells, the bacterial solution was ultrasonically lysed for 30 minutes, and the supernatant was collected by centrifugation as above and combined with 4ml of glutathione-Sepharose 4B; then SDS-PAGE gel electrophoresis was performed, and the results are shown in Figure 4 , it can be seen that a large number of hypothetical...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention relates to an A1S-1462 recombinant protein and a preparation method and application thereof. The recombinant protein comprises A1S-1462 mature peptide, and the amino acid sequence of the recombinant protein is shown as SEQ ID NO. 3. The recombinant protein is high in expression amount, easy to separate and purify, efficient and safe, can be directly used with an adjuvant, and is used for the preparation of an acinetobacter baumannii infection resistant subunit vaccine and a related detection kit. Confirmed by animal experiments, the genetic engineering recombinant subunit vaccine has good acinetobacter baumannii infection resistant immune protection effect, lays a foundation for the further study on combined vaccines and multicomponent fusion vaccines, and plays an important role for development and application of prevention and control vaccines and diagnostic kits.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to the hypothetical protein A1S_1462 protein of Acinetobacter baumannii and its preparation method and application. Background technique [0002] Acinetobacter baumannii (Acinetobacter baumannii) is a non-fermenting gram-negative bacillus, which widely exists in nature and belongs to conditional pathogenic bacteria. This bacterium is an important pathogen of nosocomial infection, mainly causing respiratory tract infection, and can also cause bacteremia, urinary tract infection, secondary meningitis, surgical site infection, ventilator-associated pneumonia, etc. Domestic data show that Acinetobacter baumannii accounts for more than 70% of clinically isolated Acinetobacter. The resistance rate of Acinetobacter baumannii to the third and fourth generation cephalosporins has reached 63.0% to 89.9%. The resistance rate to four aminoglycosides (amikacin, gentamicin, netilmicin, tobramycin) ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/22C07K19/00C12N15/31C12N15/62C12N15/70C12N1/21C07K16/12A61K39/02A61P31/04
CPCA61K39/02C07K14/22C07K16/1217C07K2319/23
Inventor 蔡昌芝曾浩邹全明冯强石云魏振波
Owner ARMY MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com